PHAT
Phathom Pharmaceuticals, Inc.Healthcare$11.55
◆ Neutral
Mkt Cap: $910.1MFloat: 59.2MSI: 19.7%DTC: 12.2
Data as of market close Apr 7, 2026
IV Rank
42
IV Pctl
38%
HV 20d
57.4%
52W Range
$2-$18
ATR(14)
$0.69
Exp. Move
±44.6%
P/C Ratio
0.32
Earnings
Apr 30
GEX Positive
DEX Long
Net Put Premium
IV Moderate
Max Pain Below
Exp. Move Wide
Low Put/Call
PHAT Key Options Data
- IV Rank
- 42.2%
- Total GEX
- $0.00B
- Total DEX
- $0.1M
- Max Pain
- $10.00
- Expected Move
- ±44.6%
- Put/Call OI
- 0.32
- Net Premium
- $-0.1M
- Spot Price
- $11.55
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 10 | ±$5.15 | ±44.6% | $6.40 | $16.70 |
| 2026-05-15 | 38 | ±$4.65 | ±40.3% | $6.90 | $16.20 |
| 2026-08-21 | 136 | ±$5.80 | ±50.2% | $5.75 | $17.35 |
| 2027-01-15 | 283 | ±$3.62 | ±31.4% | $7.93 | $15.18 |
Explore PHAT options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.